Markston International LLC cut its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 6.4% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 155,205 shares of the pharmacy operator’s stock after selling 10,563 shares during the quarter. Walgreens Boots Alliance makes up 1.2% of Markston International LLC’s portfolio, making the stock its 29th largest holding. Markston International LLC’s holdings in Walgreens Boots Alliance were worth $11,271,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently modified their holdings of the company. Commonwealth Bank of Australia raised its holdings in shares of Walgreens Boots Alliance by 139.5% in the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock valued at $3,614,000 after buying an additional 26,893 shares during the last quarter. Andra AP fonden increased its position in Walgreens Boots Alliance by 6.9% in the third quarter. Andra AP fonden now owns 62,300 shares of the pharmacy operator’s stock worth $4,811,000 after purchasing an additional 4,000 shares during the period. Schwab Charles Investment Management Inc. increased its position in Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after purchasing an additional 154,995 shares during the period. Birinyi Associates Inc. increased its position in Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after purchasing an additional 750 shares during the period. Finally, Legal & General Group Plc increased its position in Walgreens Boots Alliance by 5.2% in the second quarter. Legal & General Group Plc now owns 4,550,856 shares of the pharmacy operator’s stock worth $356,368,000 after purchasing an additional 223,186 shares during the period. 61.57% of the stock is owned by institutional investors.
In other news, insider Stefano Pessina bought 98,858 shares of the business’s stock in a transaction on Monday, January 15th. The shares were purchased at an average price of $76.07 per share, for a total transaction of $7,520,128.06. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 14.80% of the company’s stock.
A number of analysts recently commented on the company. Needham & Company LLC reiterated a “buy” rating and issued a $88.00 price objective (up from $86.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, January 10th. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research report on Wednesday, January 10th. Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Thursday, October 26th. ValuEngine lowered Walgreens Boots Alliance from a “buy” rating to a “hold” rating in a research report on Friday, February 2nd. Finally, Robert W. Baird restated an “outperform” rating and set a $80.00 target price (down from $90.00) on shares of Walgreens Boots Alliance in a research report on Thursday, October 19th. They noted that the move was a valuation call. Eleven investment analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $85.53.
Walgreens Boots Alliance Inc (NASDAQ:WBA) opened at $68.46 on Tuesday. The firm has a market capitalization of $67,820.00, a PE ratio of 18.91, a PEG ratio of 1.16 and a beta of 1.18. The company has a current ratio of 0.96, a quick ratio of 0.47 and a debt-to-equity ratio of 0.48. Walgreens Boots Alliance Inc has a 1-year low of $63.82 and a 1-year high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.27 by $0.01. The firm had revenue of $30.74 billion for the quarter, compared to analysts’ expectations of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.10 EPS. analysts forecast that Walgreens Boots Alliance Inc will post 5.71 earnings per share for the current fiscal year.
Walgreens Boots Alliance announced that its Board of Directors has initiated a share repurchase program on Wednesday, October 25th that authorizes the company to buyback $1.00 billion in outstanding shares. This buyback authorization authorizes the pharmacy operator to reacquire shares of its stock through open market purchases. Stock buyback programs are often an indication that the company’s leadership believes its stock is undervalued.
The company also recently announced a quarterly dividend, which will be paid on Monday, March 12th. Shareholders of record on Thursday, February 15th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend is Wednesday, February 14th. Walgreens Boots Alliance’s payout ratio is 44.20%.
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.dispatchtribunal.com/2018/02/13/markston-international-llc-sells-10563-shares-of-walgreens-boots-alliance-inc-wba.html.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.